Browse

You are looking at 71 - 80 of 1,147 items for :

  • Refine by Content Type: News x
Clear All Modify Search

ASN continues to move forward on its commitment to dismantle systemic racism in nephrology. These are complex issues that can limit the ability of nephrologists and kidney health professionals to provide optimal care to patients or to reach their full career potential.

Taking part in the 9th Annual Kidney Health Advocacy Day, advocates from the American Association of Kidney Patients (AAKP) and ASN are urging their congressional delegations to increase funding for kidney research at the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) to drive new breakthroughs for kidney patients and study the impact of COVID-19 on kidney health and people with kidney diseases.

Advocates from the American Association of Kidney Patients (AAKP) and ASN are calling on Congress to include funding for KidneyX in its annual government funding legislation and advance innovative technologies for kidney patients, such as a wearable or implantable artificial kidney.

In response to a Request for Information (RFI), ASN recently submitted comments to the National Institutes of Health (NIH) with input from the ASN Diversity, Equity, and Inclusion Committee, the ASN Health Care Justice Committee, and the ASN Policy and Advocacy Committee.

Last month, ASN and NKF asserted that race should not be included in kidney function estimating equations and that a suitable approach be put in its place that is accurate; representative for all regardless of race, ethnicity, age, or sex; not differentially produce bias, inaccuracy, or inequalities; and be standardized across the United States. Producing such a national standard depends on coordinating efforts to replace the existing equations for estimating kidney function with a suitable approach.

Today, the Journal of the American Society of Nephrology (JASN) and the American Journal of Kidney Diseases (AJKD) published the interim report of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.

Office of the President, American Society of Nephrology

An unprecedented collaboration between the White House, the Centers for Disease Control, the American Society of Nephrology, and dialysis organizations across the United States resulted in this historic action.

In support of increasing living donation, especially living kidney donation for people with kidney failure, ASN applauds today’s reintroduction of the Living Donor Protection Act of 2021 by Representatives Jerry Nadler (D-NY) and Jaime Herrera-Beulter (R-WA), and Senators Kristen Gillibrand (D-NY) and Tom Cotton (R-AR).  

The next 10 years have been dubbed the "decade of the kidney." To realize this promise, we must improve care, expand research, and bolster education by 2030. The first step is recognizing the urgent need to translate innovation into reality for the more than 850 million people worldwide with kidney diseases, kidney failure, and kidney transplants.

"Michelle was an incredible physician scientist and human being. She was the heart and soul of our podocyte community. To me, she was the perfect role model, and exemplified everything that is good in medicine and the world. I feel privileged to have counted her as a colleague, a confidante and most of all, my friend. Her passing left many of us heartbroken. To her tribute, her legacy lives on in her many groundbreaking discoveries and amazing nephrologists like Dr. Gentzon."  -- Susan E. Quaggin, MD, FASN,  President, American Society of Nephrology

Kidney transplantation saves lives. For many people with kidney failure, transplant offers longer survival, greater quality of life, and lower associated costs compared to dialysis.